World Top 100 Biotechnology Companies List by Market Cap in January 2024

World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.

World Top Biotechnology Companies in 2024
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.

  1. Amicus Therapeutics

    World Rank (Jan-05-2024)
    3,532
    Market Cap (Jan-05-2024)
    3.968 Billion USD
    World Rank (Jul-30-2023)
    3,630
    Market Cap (Jul-30-2023)
    3.862 Billion USD
    World Rank (Dec-25-2022)
    3,839
    Market Cap (Dec-25-2022)
    3.279 Billion USD
    World Rank (Jan-07-2022)
    4,637
    Market Cap (Jan-07-2022)
    3.18 Billion USD
    Annual Revenue in USD
    329 Million USD
    Annual Operating Income in USD
    -204 Million USD
    Annual Net Income in USD
    -236 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Amicus Therapeutics is a Biotechnology company. The headquarters is in USA.

    Company Website
    AMICUS THERAPEUTICS INC
    Wikipedia
    Wikipedia

  2. Ultragenyx Pharmaceutical

    World Rank (Jan-05-2024)
    3,549
    Market Cap (Jan-05-2024)
    3.941 Billion USD
    World Rank (Jul-30-2023)
    4,303
    Market Cap (Jul-30-2023)
    3.053 Billion USD
    World Rank (Dec-25-2022)
    4,035
    Market Cap (Dec-25-2022)
    3.051 Billion USD
    World Rank (Jan-07-2022)
    3,267
    Market Cap (Jan-07-2022)
    5.03 Billion USD
    Annual Revenue in USD
    363 Million USD
    Annual Operating Income in USD
    -648 Million USD
    Annual Net Income in USD
    -707 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Ultragenyx Pharmaceutical is a Clinical Stage Biopharmaceutical company. It committed to bringing to patients novel products for the treatment of rare and ultra rare diseases with a focus on serious debilitating genetic diseases. The company portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for which there are no approved therapies. The headquarters is in USA.

    Company Website
    ULTRAGENYX PHARMACEUTICAL INC

  3. Axsome Therapeutics Inc

    World Rank (Jan-05-2024)
    3,583
    Market Cap (Jan-05-2024)
    3.880 Billion USD
    World Rank (Jul-30-2023)
    6,099
    Market Cap (Jul-30-2023)
    1.818 Billion USD
    World Rank (Dec-25-2022)
    5,910
    Market Cap (Dec-25-2022)
    1.753 Billion USD
    Headquarters Country
    USA
    Company Profile
    AXSOME THERAPEUTICS INC is a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The headquarters is in USA.
    Company Website
    AXSOME THERAPEUTICS INC

  4. Axsome Therapeutics

    World Rank (Jan-05-2024)
    3,584
    Market Cap (Jan-05-2024)
    3.880 Billion USD
    World Rank (Jul-30-2023)
    3,778
    Market Cap (Jul-30-2023)
    3.664 Billion USD
    World Rank (Dec-25-2022)
    3,898
    Market Cap (Dec-25-2022)
    3.204 Billion USD
    World Rank (Jan-07-2022)
    8,340
    Market Cap (Jan-07-2022)
    1.24 Billion USD
    Annual Revenue in USD
    50 Million USD
    Annual Operating Income in USD
    -176 Million USD
    Annual Net Income in USD
    -187 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Axsome Therapeutics is a biopharmaceutical company. The headquarters is in USA.

    Company Website
    AXSOME THERAPEUTICS

  5. MyoKardia

    World Rank (Jan-05-2024)
    3,600
    World Rank (Jul-30-2023)
    3,600
    World Rank (Dec-25-2022)
    3,600
    World Rank (Jan-07-2022)
    3,600
    Headquarters Country
    USA
    Company Profile

    MyoKardia is a Transformative Therapies company. It is applying a precision medicine approach to develop therapeutic candidates for patient populations with shared characteristics such as causal genetic mutations or disease subtypes. The headquarters is in USA.

    Bristol Myers Squibb acquired MyoKardia for 13.1 Billion USD in Nov-2020.

     

    Facts About Company

    Bristol Myers Squibb acquired MyoKardia for 13.1 Billion USD in Nov-2020

    Company Website
    MYOKARDIA INC

  6. Yunnan Botanee Bio-Technology Group Co. Ltd

    World Rank (Jan-05-2024)
    3,602
    Market Cap (Jan-05-2024)
    3.854 Billion USD
    World Rank (Jul-30-2023)
    2,466
    Market Cap (Jul-30-2023)
    6.205 Billion USD
    World Rank (Dec-25-2022)
    1,733
    Market Cap (Dec-25-2022)
    8.609 Billion USD
    World Rank (Jan-07-2022)
    1,675
    Market Cap (Jan-07-2022)
    11.47 Billion USD
    Annual Revenue in USD
    703 Million USD
    Annual Operating Income in USD
    160 Million USD
    Annual Net Income in USD
    147 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    China
    Company Profile
    Skin care products manufacturing company with headquarters is in China.
    Company Website
    YUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO.LTD

  7. Turning Point Therapeutics

    World Rank (Jan-05-2024)
    3,662
    World Rank (Jul-30-2023)
    3,662
    Market Cap (Jul-30-2023)
    3.810 Billion USD
    World Rank (Dec-25-2022)
    6,535
    Market Cap (Dec-25-2022)
    1.510 Billion USD
    World Rank (Jan-07-2022)
    6,033
    Market Cap (Jan-07-2022)
    2.13 Billion USD
    Annual Revenue in USD
    30 Million USD
    Annual Net Income in USD
    -236 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Company Profile

    Turning Point Therapeutics is a clinical-stage biopharmaceutical company designing and developing novel small molecule, targeted oncology therapies to address key limitations of existing therapies and improve the lives of patients. Headquarters is in USA.

    Turning Point develops kinase inhibitors, a class of targeted cancer drugs, that are designed to bind to cancer cells with greater precision and affinity than existing therapies.

    Company Website
    TURNING POINT THERAPEUTICS

  8. Pharmaessentia Corporation

    World Rank (Jan-05-2024)
    3,704
    Market Cap (Jan-05-2024)
    3.726 Billion USD
    World Rank (Jul-30-2023)
    3,671
    Market Cap (Jul-30-2023)
    3.797 Billion USD
    World Rank (Dec-25-2022)
    2,835
    Market Cap (Dec-25-2022)
    4.782 Billion USD
    World Rank (Jan-07-2022)
    5,518
    Market Cap (Jan-07-2022)
    2.47 Billion USD
    Headquarters Country
    Taiwan
    Yahoo @ Taiwan
    Company Profile
    PHARMAESSENTIA CORPORATION is a fully integrated global biopharmaceutical company delivering efficacious, safe and cost effective therapeutic products for the treatment of human diseases. The headquarters is in China.
    Company Website
    PHARMAESSENTIA CORPORATION

  9. Haisco Pharmaceutical Group

    World Rank (Jan-05-2024)
    3,705
    Market Cap (Jan-05-2024)
    3.725 Billion USD
    World Rank (Jul-30-2023)
    3,761
    Market Cap (Jul-30-2023)
    3.688 Billion USD
    World Rank (Dec-25-2022)
    3,889
    Market Cap (Dec-25-2022)
    3.219 Billion USD
    World Rank (Jan-07-2022)
    4,526
    Market Cap (Jan-07-2022)
    3.29 Billion USD
    Annual Revenue in USD
    404 Million USD
    Annual Net Income in USD
    50 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    China
    Yahoo @ Shenzhen
    Company Profile
    HAISCO PHARMACEUTICAL GROUP is a chemical pharmaceutical industries company with manufacturer of drugs for liver disease. The company specialized fields of innovative drugs and high end generic drugs involving multiple disease fields such as anaesthesia and analgesia, diabetes mellitus and complications, tumour, neuralgia, parenteral nutrition, cardio-cerebrovascular, digestive and respiratory diseases. The headquarters is in China.
    Company Website
    HAISCO PHARMACEUTICAL GROUP

  10. RayzeBio Inc.

    World Rank (Jan-05-2024)
    3,716
    Market Cap (Jan-05-2024)
    3.711 Billion USD
    World Rank (Jul-30-2023)
    7,834
    Market Cap (Jul-30-2023)
    1.205 Billion USD
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    RayzeBio is building a vertically integrated radiopharmaceutical therapeutics (RPT) company to treat various cancers, with its lead program in a Phase 3 clinical trial. Headquarters is in USA.

    Company Website
    RAYZEBIO INC.

Share